Tech Company Financing Transactions

Acceleron Pharma Funding Round

Advanced Technology Ventures, Avalon Ventures and Bessemer Venture Partners participated in a $30 million funding round for Acceleron Pharma. The round was announced on 12/23/2011.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

128 Sidney St.
Cambridge, MA 02139
USA

Phone

(617) 649-9200

Website

www.acceleronpharma.com

Email Address

[email protected]

Overview

Acceleron is dedicated to the discovery and development of innovative, life-changing medicines for patients with a wide range of serious and rare diseases. Our research focuses on harnessing the power of the TGF-beta protein superfamily, the target-rich area of biology behind the body's remarkable capacity for cellular growth and repair.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Habib Dable

        

Chief Financial Officer

Kevin McLaughlin

        

Chief Scientific Officer

Ravi Kumar

        

Vice President

Todd James

        

VP - Bus. Development

Sujay Kango

        

VP - Bus. Development

John Quisel

        

VP - Bus. Development

Tracey Sacco

        

VP - General Counsel

Adam Veness

        

VP - Human Resources

Kevin McManus

        

VP - Regulatory Affairs

James Desiderio

        

Browse more venture capital transactions:

Prev: 12/23/2011: Napkin Labs venture capital transaction
Next: 12/23/2011: Daktari Diagnostics venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary